drugset / Trial / NCT01037504

AZD5423 Multiple Ascending Dose Study

NCT01037504

Phase 1 Completed 27 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5423 following multiple ascending dose administrations in healthy male and female subjects

Timeline

Start
2010-01
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5423 Other / unclassified Inhaled

Indications

No indication recorded.